(19)
(11) EP 1 313 719 A2

(12)

(88) Date of publication A3:
30.05.2002

(43) Date of publication:
28.05.2003 Bulletin 2003/22

(21) Application number: 01958860.7

(22) Date of filing: 27.07.2001
(51) International Patent Classification (IPC)7C07D 277/68, A61K 31/395, A61P 43/00, C07D 263/58, C07D 209/34, C07D 215/22, C07D 233/26
(86) International application number:
PCT/US0121/122
(87) International publication number:
WO 0201/4275 (21.02.2002 Gazette 2002/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 11.08.2000 US 224497 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • FORMAN, Scott Louis
    Indianapolis, IN 46250 (US)
  • JONES, Winton, Dennis
    Carmel, IN 46033 (US)
  • SMITH, Daryl, Lynn
    Fishers, IN 46038 (US)
  • ZARRINMAYEH, Hamideh
    Carmel, IN 46032 (US)
  • ZIMMERMAN, Dennis, Michael
    Zionsville, IN 46077 (US)

(74) Representative: Kingsbury, Oliver William 
Eli Lilly and Company Limited,Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) HETEROCYCLIC SULFONAMIDE DERIVATIVES AND THEIR USE FOR POTENTIATING GLUTAMATE RECEPTOR FUNCTION